Tonix Pharmaceuticals Holding Stock Analysis
| TNXP Stock | USD 8.43 0.38 4.72% |
Tonix Pharmaceuticals Holding is overvalued with Real Value of 7.17 and Hype Value of 8.43. The main objective of Tonix Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what Tonix Pharmaceuticals Holding is worth, separate from its market price. There are two main types of Tonix Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The Tonix Pharmaceuticals stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Tonix Pharmaceuticals is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Tonix Stock trading window is adjusted to America/New York timezone.
Tonix |
Tonix Stock Analysis Notes
The company has price-to-book ratio of 0.66. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Tonix Pharmaceuticals recorded a loss per share of 8039.0. The entity last dividend was issued on the 1st of November 2019. The firm had 1:100 split on the 5th of February 2025. Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. The company was founded in 2007 and is headquartered in Chatham, New Jersey. Tonix Pharm operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 73 people. To find out more about Tonix Pharmaceuticals Holding contact the company at 862 799 8599 or learn more at https://www.tonixpharma.com.Tonix Pharmaceuticals Investment Alerts
| Tonix Pharmaceuticals is way too risky over 90 days horizon | |
| Tonix Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Tonix Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Tonix Pharmaceuticalshas 9,730,922 shares shorted by Tonix Pharmaceuticals investors is about 100% of outstending shares | |
| The company reported the previous year's revenue of 7.77 M. Net Loss for the year was (116.66 M) with profit before overhead, payroll, taxes, and interest of 2.34 M. | |
| Tonix Pharmaceuticals Holding currently holds about 145.48 M in cash with (102 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.38. |
Tonix Pharmaceuticals Upcoming and Recent Events
| 11th of March 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 11th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Tonix Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 45 M.Technical Drivers
As of the 27th of February, Tonix Pharmaceuticals has the Risk Adjusted Performance of 0.0305, coefficient of variation of 3538.41, and Semi Deviation of 15.29. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Tonix Pharmaceuticals, as well as the relationship between them.Tonix Pharmaceuticals Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Tonix Pharmaceuticals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Tonix Pharmaceuticals. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Tonix Pharmaceuticals Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Tonix Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Tonix Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Tonix Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Tonix Pharmaceuticals Outstanding Bonds
Tonix Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Tonix Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Tonix bonds can be classified according to their maturity, which is the date when Tonix Pharmaceuticals Holding has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Tonix Pharmaceuticals Predictive Daily Indicators
Tonix Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Tonix Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Tonix Pharmaceuticals Forecast Models
Tonix Pharmaceuticals' time-series forecasting models are one of many Tonix Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Tonix Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Tonix Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Tonix Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Tonix shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Tonix Pharmaceuticals. By using and applying Tonix Stock analysis, traders can create a robust methodology for identifying Tonix entry and exit points for their positions.
Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. The company was founded in 2007 and is headquartered in Chatham, New Jersey. Tonix Pharm operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 73 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Tonix Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
| All Next | Launch Module |
Additional Tools for Tonix Stock Analysis
When running Tonix Pharmaceuticals' price analysis, check to measure Tonix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tonix Pharmaceuticals is operating at the current time. Most of Tonix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tonix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tonix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tonix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.